In several murine cancer models, CHOP was shown to prevent IFNγ expression in intratumoral CD8+ T cells through direct inhibition of the type 1 helper cell transcription factor TH1 (T‐box) on T cells [116], decrease glycolytic pathway activity, and reduce mitochondrial respiration in CD8+ T cells [116]. The gene discussed is CD8A; the disease is cancer.